Amedica Drug Screen Thc/Coc, OP1300, Ppx, Oxy, Bar/Bzo Test
510(k) K040464
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK040464 | Date17 May 2004 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LDJ
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3870
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
The AMEDICA DRUG SCREEN THC/COC, OP1300, PPX, OXY, BAR/BZO TEST is an in vitro diagnostic test for the rapid detection of specific substances in human urine. It detects THC, benzoylecgonine, morphine, propoxyphene, oxycodone, secobarbital and oxazepam at defined cut-off concentrations. The device is classified under enzyme immunoassay technology and falls within the clinical toxicology specialty.
This single-use diagnostic test is designed for point-of-care or laboratory settings and is supplied as a ready-to-use assay. It is regulated under FDA 510(k) clearance with product code LDJ and is intended for in vitro use only. The device is not evaluated for MRI compatibility and should be stored according to manufacturer specifications. Authorizations include FDA 510(k) with decision date 2004-05-17 and substantial equivalence determination.